ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05164	Influenza A	11/61	167/7206	1.14290928613e-07
ko04621	NOD-like receptor signaling pathway	10/61	157/7206	6.28070280218e-07
ko05160	Hepatitis C	9/61	153/7206	4.68236334842e-06
ko05168	Herpes simplex infection	9/61	182/7206	1.91816202355e-05
ko04060	Cytokine-cytokine receptor interaction	9/61	191/7206	2.81826469778e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	9/61	191/7206	2.81826469778e-05
ko05162	Measles	7/61	120/7206	6.17493636996e-05
ko04668	TNF signaling pathway	7/61	120/7206	6.17493636996e-05
ko04660	T cell receptor signaling pathway	7/61	124/7206	7.61039071084e-05
ko04630	Jak-STAT signaling pathway	7/61	132/7206	0.000113027888991
ko04380	Osteoclast differentiation	7/61	134/7206	0.000124234573052
ko04064	NF-kappa B signaling pathway	6/61	96/7206	0.000146947353053
ko04622	RIG-I-like receptor signaling pathway	5/61	62/7206	0.000164484382845
ko05161	Hepatitis B	7/61	173/7206	0.000595664017328
ko05131	Shigellosis	5/61	82/7206	0.000609405846519
ko05145	Toxoplasmosis	6/61	126/7206	0.000641426874222
ko04217	Necroptosis	7/61	178/7206	0.000706039319053
ko04620	Toll-like receptor signaling pathway	5/61	100/7206	0.00149703938341
ko05169	Epstein-Barr virus infection	7/61	206/7206	0.00165950964669
ko05150	Staphylococcus aureus infection	3/61	36/7206	0.00337859577902
ko05134	Legionellosis	4/61	74/7206	0.00343765963694
ko04672	Intestinal immune network for IgA production	3/61	37/7206	0.00365472736766
ko04210	Apoptosis	6/61	180/7206	0.00397356799016
ko04932	Non-alcoholic fatty liver disease (NAFLD)	6/61	182/7206	0.00419480565804
ko05142	Chagas disease (American trypanosomiasis)	5/61	130/7206	0.00469185050286
ko05152	Tuberculosis	6/61	187/7206	0.00478787377107
ko04623	Cytosolic DNA-sensing pathway	3/61	41/7206	0.0048953459019
ko04931	Insulin resistance	5/61	137/7206	0.00585382534236
ko05133	Pertussis	4/61	87/7206	0.00612964384789
ko04662	B cell receptor signaling pathway	4/61	88/7206	0.00638145023295
ko05323	Rheumatoid arthritis	4/61	89/7206	0.00664005630189
ko04920	Adipocytokine signaling pathway	4/61	89/7206	0.00664005630189
ko04062	Chemokine signaling pathway	6/61	201/7206	0.00677797669156
ko04215	Apoptosis - multiple species	3/61	47/7206	0.00718384568488
ko05120	Epithelial cell signaling in Helicobacter pylori infection	4/61	92/7206	0.00745744781568
ko05166	HTLV-I infection	7/61	292/7206	0.0111730122085
ko04211	Longevity regulating pathway	4/61	123/7206	0.0199712982265
ko05340	Primary immunodeficiency	2/61	30/7206	0.0263389989878
ko04612	Antigen processing and presentation	3/61	77/7206	0.0271142809699
ko05203	Viral carcinogenesis	6/61	277/7206	0.0289317267864
ko04610	Complement and coagulation cascades	3/61	79/7206	0.0289674402818
ko05220	Chronic myeloid leukemia	3/61	85/7206	0.0349214209195
ko04657	IL-17 signaling pathway	3/61	87/7206	0.0370367068751
ko05222	Small cell lung cancer	3/61	89/7206	0.0392167478353
ko04722	Neurotrophin signaling pathway	4/61	160/7206	0.046003581145
ko04725	Cholinergic synapse	4/61	160/7206	0.046003581145
ko04658	Th1 and Th2 cell differentiation	3/61	96/7206	0.0473506561829
ko04650	Natural killer cell mediated cytotoxicity	3/61	97/7206	0.048575799279
ko04611	Platelet activation	4/61	163/7206	0.048678821586